{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:14:21Z","timestamp":1762985661134,"version":"3.45.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":266,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jvsvs.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JVS-Vascular Science"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.jvssci.2020.09.003","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T03:00:43Z","timestamp":1603335643000},"page":"200-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cilostazol as a noninferiority pharmacologic option to paclitaxel in early intimal hyperplasia inhibition after venous balloon angioplasty in a rabbit model: a preliminary study"],"prefix":"10.1016","volume":"1","author":[{"given":"Rodrigo","family":"Lozano-Corona","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Laparra-Escareno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier E.","family":"Anaya-Ayala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Zentella-Dehesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus J.","family":"Baquera-Heredia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Arg\u00fcero-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Hinojosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Fitridge R Thompson M editors","key":"10.1016\/j.jvssci.2020.09.003_bib1"},{"key":"10.1016\/j.jvssci.2020.09.003_bib2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/01.ATV.0000208185.16371.97","article-title":"Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes: distinct responses to stimuli","volume":"26","author":"Deng","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvssci.2020.09.003_bib3","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1681\/ASN.2016121355","article-title":"Intimal hyperplasia, stenosis and arteriovenous fistula maturation failure in the hemodialysis fistula maturation study","volume":"28","author":"Cheung","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jvssci.2020.09.003_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0741-5214(03)01028-0","article-title":"In-stent recurrent stenosis in stents placed in the lower extremity venous outflow tract","volume":"39","author":"Negl\u00e9n","year":"2004","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvssci.2020.09.003_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0741-5214(94)70110-5","article-title":"Intimal hyperplasia producing thrombus organization in an experimental venous thrombosis model","volume":"19","author":"Sigel","year":"1994","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvssci.2020.09.003_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.14797\/mdcj-9-2-69","article-title":"Endovascular techniques in limb salvage: cutting, cryo, brachy, and drug-eluting balloons","volume":"9","author":"Davies","year":"2013","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.jvssci.2020.09.003_bib7","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ejvs.2018.02.001","article-title":"Vascular access: 2018 clinical practice guidelines of the European Society for Vascular Surgery (ESVS)","volume":"55","author":"Schmidli","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvssci.2020.09.003_bib8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s002709900373","article-title":"Effect of antithrombotic agents on the patency of PTFE-covered stents in the inferior vena cava: an experimental study","volume":"22","author":"Makutani","year":"1999","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"Suppl B","key":"10.1016\/j.jvssci.2020.09.003_bib9","first-page":"56B","article-title":"The vascular effects of cilostazol","volume":"22","author":"Weintraub","year":"2006","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jvssci.2020.09.003_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/1358863X9700200304","article-title":"Mechanisms of neointima formation\u2014lessons from experimental models","volume":"2","author":"De Meyer","year":"1997","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvssci.2020.09.003_bib13","first-page":"17","article-title":"Modelo experimental biol\u00f3gico y molecular de fuerza tensional para el estudio fisiopatol\u00f3gico de la hiperplasia intimal venosa","volume":"48","author":"Laparra-Escareno","year":"2020","journal-title":"Rev Mex Angiol"},{"key":"10.1016\/j.jvssci.2020.09.003_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10557-016-6658-1","article-title":"Paclitaxel-coated balloons: investigation of drug transfer in healthy and atherosclerotic arteries\u2014first experimental results in rabbits at low inflation pressure","volume":"30","author":"Stolzenburg","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jvssci.2020.09.003_bib15","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10439-005-4854-4","article-title":"The effect of fixation and histological preparation on coronary artery dimensions","volume":"33","author":"Choy","year":"2005","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.jvssci.2020.09.003_bib16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.avsg.2013.10.007","article-title":"Supplemental oxygen reverses hypoxia-induced smooth muscle cell proliferation by modulating HIF-alpha and VEGF levels in a rabbit arteriovenous fistula model","volume":"28","author":"Wan","year":"2013","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvssci.2020.09.003_bib17","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/his.12507","article-title":"A\u00a0comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies","volume":"65","author":"Koh","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.jvssci.2020.09.003_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005344-200102000-00003","article-title":"Suppression of cell proliferation by tissue plasminogen activator during the early phase after balloon injury minimizes intimal hyperplasia in hypercholesterolemic rabbits","volume":"37","author":"Kanamasa","year":"2001","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jvssci.2020.09.003_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/03007995.2017.1372114","article-title":"Drug-delivering endovascular treatment versus angioplasty in artery occlusion diseases: a systematic review and meta-analysis","volume":"34","author":"Chen","year":"2018","journal-title":"Curr Med Res Op"},{"key":"10.1016\/j.jvssci.2020.09.003_bib20","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jvs.2016.10.098","article-title":"Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease","volume":"65","author":"Zen","year":"2017","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvssci.2020.09.003_bib21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1161\/ATVBAHA.115.307011","article-title":"Induction of angiogenesis by a type III phosphodiesterase inhibitor, cilostazol, through activation of peroxisome proliferator-activated receptor-\u03b3 and cAMP pathways in vascular cells","volume":"36","author":"Sanada","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvssci.2020.09.003_bib22","doi-asserted-by":"crossref","first-page":"E5429","DOI":"10.1073\/pnas.1421438111","article-title":"Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells","volume":"111","author":"Samanta","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jvssci.2020.09.003_bib23","first-page":"9","article-title":"Behavior of smooth muscle cells under hypoxic conditions: possible implications on the varicose vein endothelium","volume":"1","author":"Ortega","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jvssci.2020.09.003_bib24","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1111\/febs.13062","article-title":"Hypoxia-inducible factor-2\u03b1 (HIF-2\u03b1), but not HIF-1\u03b1, is essential for hypoxic induction of class III \u03b2-tubulin expression in human glioblastoma cells","volume":"18","author":"Bordji","year":"2014","journal-title":"FEBS J"}],"container-title":["JVS-Vascular Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666350320300249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666350320300249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:13:36Z","timestamp":1762982016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666350320300249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":22,"alternative-id":["S2666350320300249"],"URL":"https:\/\/doi.org\/10.1016\/j.jvssci.2020.09.003","relation":{},"ISSN":["2666-3503"],"issn-type":[{"type":"print","value":"2666-3503"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cilostazol as a noninferiority pharmacologic option to paclitaxel in early intimal hyperplasia inhibition after venous balloon angioplasty in a rabbit model: a preliminary study","name":"articletitle","label":"Article Title"},{"value":"JVS-Vascular Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvssci.2020.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}